Jackson B. Hester Jr, Allan D. Rudzik, Bharat V. Kamdar: 6-Phenyl-4H-s-triazolo[4,3-a] [1,4]benzodiazepines which have central nervous system depressant activity. In: Journal of Medicinal Chemistry. 14. Jahrgang, Nr.11, November 1971, S.1078–1081, doi:10.1021/jm00293a015, PMID 5165540.
Laura M. Huppertz, Philippe Bisel, Folker Westphal, Florian Franz, Volker Auwärter, Bjoern Moosmann: Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites. In: Forensic Toxicology. 33. Jahrgang, Nr.2, Juli 2015, S.388–395, doi:10.1007/s11419-015-0277-6.
Markus R. Meyer, Madeleine Pettersson Bergstrand, Anders Helander, Olof Beck: Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. In: Analytical and Bioanalytical Chemistry. 408. Jahrgang, Nr.13, Mai 2016, S.3571–3591, doi:10.1007/s00216-016-9439-6, PMID 27071765.
M. Chaslot, S. El Balkhi, T. Robin, J. Morichon, N. Picard, F. Saint-Marcoux: Exploration des métabolites de 8 benzodiazépines de synthèse. In: Toxicologie Analytique et Clinique. 28. Jahrgang, Nr.2, Juni 2016, S.S32, doi:10.1016/j.toxac.2016.03.053.
Madeleine Pettersson Bergstrand, Anders Helander, Therese Hansson, Olof Beck: Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays. In: Drug Testing and Analysis. 2016, doi:10.1002/dta.2003, PMID 27366870.
Gudrun Høiseth, Silja Skogstad Tuv, Ritva Karinen: Blood concentrations of new designer benzodiazepines in forensic cases. In: Forensic Science International. 268. Jahrgang, 2016, S.35–38, doi:10.1016/j.forsciint.2016.09.006, PMID 27685473.
Bjoern Moosmann, Leslie A King, Volker Auwärter: Designer benzodiazepines: A new challenge. In: World Psychiatry. 14. Jahrgang, Nr.2, Juni 2015, S.248, doi:10.1002/wps.20236, PMID 26043347, PMC 4471986 (freier Volltext).
espacenet.com
worldwide.espacenet.com
Patent EP0072029B1: Triazolobenzazepine, Verfahren und Zwischenprodukte zu deren Herstellung und diese enthaltende Arzneimittel. Angemeldet am 10. August 1982, veröffentlicht am 22. Oktober 1986, Anmelder: F. Hoffmann-La Roche & Co Aktiengesellschaft, Erfinder: René Borer, Max Gerecke, Emilio Kyburz.
Jackson B. Hester Jr, Allan D. Rudzik, Bharat V. Kamdar: 6-Phenyl-4H-s-triazolo[4,3-a] [1,4]benzodiazepines which have central nervous system depressant activity. In: Journal of Medicinal Chemistry. 14. Jahrgang, Nr.11, November 1971, S.1078–1081, doi:10.1021/jm00293a015, PMID 5165540.
Markus R. Meyer, Madeleine Pettersson Bergstrand, Anders Helander, Olof Beck: Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. In: Analytical and Bioanalytical Chemistry. 408. Jahrgang, Nr.13, Mai 2016, S.3571–3591, doi:10.1007/s00216-016-9439-6, PMID 27071765.
Madeleine Pettersson Bergstrand, Anders Helander, Therese Hansson, Olof Beck: Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays. In: Drug Testing and Analysis. 2016, doi:10.1002/dta.2003, PMID 27366870.
Gudrun Høiseth, Silja Skogstad Tuv, Ritva Karinen: Blood concentrations of new designer benzodiazepines in forensic cases. In: Forensic Science International. 268. Jahrgang, 2016, S.35–38, doi:10.1016/j.forsciint.2016.09.006, PMID 27685473.
Bjoern Moosmann, Leslie A King, Volker Auwärter: Designer benzodiazepines: A new challenge. In: World Psychiatry. 14. Jahrgang, Nr.2, Juni 2015, S.248, doi:10.1002/wps.20236, PMID 26043347, PMC 4471986 (freier Volltext).
